Champions Oncology Statistics
Total Valuation
CSBR has a market cap or net worth of $93.35 million. The enterprise value is $88.95 million.
Important Dates
The next estimated earnings date is Wednesday, December 10, 2025, after market close.
| Earnings Date | Dec 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CSBR has 13.79 million shares outstanding. The number of shares has increased by 4.67% in one year.
| Current Share Class | 13.79M |
| Shares Outstanding | 13.79M |
| Shares Change (YoY) | +4.67% |
| Shares Change (QoQ) | +0.25% |
| Owned by Insiders (%) | 26.58% |
| Owned by Institutions (%) | 11.26% |
| Float | 5.11M |
Valuation Ratios
The trailing PE ratio is 31.73 and the forward PE ratio is 45.13.
| PE Ratio | 31.73 |
| Forward PE | 45.13 |
| PS Ratio | 1.63 |
| Forward PS | 1.99 |
| PB Ratio | 26.61 |
| P/TBV Ratio | 29.42 |
| P/FCF Ratio | 12.89 |
| P/OCF Ratio | 12.16 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 19.51, with an EV/FCF ratio of 12.29.
| EV / Earnings | 30.13 |
| EV / Sales | 1.56 |
| EV / EBITDA | 19.51 |
| EV / EBIT | 29.55 |
| EV / FCF | 12.29 |
Financial Position
The company has a current ratio of 0.93, with a Debt / Equity ratio of 1.68.
| Current Ratio | 0.93 |
| Quick Ratio | 0.87 |
| Debt / Equity | 1.68 |
| Debt / EBITDA | 0.93 |
| Debt / FCF | 0.82 |
| Interest Coverage | 111.48 |
Financial Efficiency
Return on equity (ROE) is 182.28% and return on invested capital (ROIC) is 23.16%.
| Return on Equity (ROE) | 182.28% |
| Return on Assets (ROA) | 6.78% |
| Return on Invested Capital (ROIC) | 23.16% |
| Return on Capital Employed (ROCE) | 38.35% |
| Revenue Per Employee | $267,033 |
| Profits Per Employee | $13,859 |
| Employee Count | 213 |
| Asset Turnover | 2.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -82,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +56.71% in the last 52 weeks. The beta is 0.34, so CSBR's price volatility has been lower than the market average.
| Beta (5Y) | 0.34 |
| 52-Week Price Change | +56.71% |
| 50-Day Moving Average | 6.69 |
| 200-Day Moving Average | 7.52 |
| Relative Strength Index (RSI) | 50.15 |
| Average Volume (20 Days) | 10,824 |
Short Selling Information
The latest short interest is 83,372, so 0.60% of the outstanding shares have been sold short.
| Short Interest | 83,372 |
| Short Previous Month | 83,558 |
| Short % of Shares Out | 0.60% |
| Short % of Float | 1.63% |
| Short Ratio (days to cover) | 6.46 |
Income Statement
In the last 12 months, CSBR had revenue of $56.88 million and earned $2.95 million in profits. Earnings per share was $0.21.
| Revenue | 56.88M |
| Gross Profit | 27.57M |
| Operating Income | 3.01M |
| Pretax Income | 2.84M |
| Net Income | 2.95M |
| EBITDA | 4.56M |
| EBIT | 3.01M |
| Earnings Per Share (EPS) | $0.21 |
Full Income StatementBalance Sheet
The company has $10.33 million in cash and $5.93 million in debt, giving a net cash position of $4.39 million or $0.32 per share.
| Cash & Cash Equivalents | 10.33M |
| Total Debt | 5.93M |
| Net Cash | 4.39M |
| Net Cash Per Share | $0.32 |
| Equity (Book Value) | 3.54M |
| Book Value Per Share | 0.25 |
| Working Capital | -1.68M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $7.68 million and capital expenditures -$435,000, giving a free cash flow of $7.24 million.
| Operating Cash Flow | 7.68M |
| Capital Expenditures | -435,000 |
| Free Cash Flow | 7.24M |
| FCF Per Share | $0.53 |
Full Cash Flow StatementMargins
Gross margin is 48.47%, with operating and profit margins of 5.29% and 5.19%.
| Gross Margin | 48.47% |
| Operating Margin | 5.29% |
| Pretax Margin | 4.99% |
| Profit Margin | 5.19% |
| EBITDA Margin | 8.02% |
| EBIT Margin | 5.29% |
| FCF Margin | 12.73% |
Dividends & Yields
CSBR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.67% |
| Shareholder Yield | -4.67% |
| Earnings Yield | 3.16% |
| FCF Yield | 7.76% |
Analyst Forecast
The average price target for CSBR is $12.00, which is 77.25% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.00 |
| Price Target Difference | 77.25% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 18.59% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on August 12, 2015. It was a reverse split with a ratio of 1:12.
| Last Split Date | Aug 12, 2015 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
CSBR has an Altman Z-Score of 0.55 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.55 |
| Piotroski F-Score | 7 |
